Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Primary progressive multiple sclerosis: cerebrospinal fluid considerations.

Mark S Freedman1

  • 1Department of Medicine (Neurology), University of Ottawa, Ottawa Hospital General Campus, 501 Smith Road, Box 601, Ottawa, Ontario K1H 8L6, Canada. mfreedman@ottawahospital.on.ca

Multiple Sclerosis (Houndmills, Basingstoke, England)
|June 29, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Patient reported outcomes in NMOSD reflect a high disease burden and do not correlate with the EDSS.

Multiple sclerosis and related disorders·2026
Same author

Serum metabolic profile at clinical onset as predictor of multiple sclerosis activity and progression after 5 years.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same author

Long-term safety and efficacy of ponesimod in participants with relapsing multiple sclerosis: results from the phase 3 OPTIMUM 5-year long term extension study.

Journal of neurology·2026
Same author

Best practice recommendations for laboratory analysis and reporting of cerebrospinal fluid oligoclonal banding and associated tests for multiple sclerosis (MS): a consensus report from the harmonized CSF analysis for MS investigation (hCAMI) subcommittee of the Canadian society of clinical chemists (CSCC).

Clinical biochemistry·2026
Same author

Demographic and Clinical Characteristics of Aquaporin-4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder in Canadian Adults.

The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques·2026
Same author

Lipoic Acid for Treatment of Progressive Multiple Sclerosis: A Phase 2 Randomized Clinical Trial.

Neurology·2025
Same journal

Impact of multiple sclerosis disease-modifying therapies on chronic lesion tissue expansion.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same journal

Tobacco smoking disrupts bile acid and tryptophan metabolism in multiple sclerosis.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same journal

Missed radiologic disease activity by conventional side-by-side MRI comparison is associated with future disease activity in multiple sclerosis: Adopting semiautomated coregistration-fusion into clinical practice.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same journal

Longitudinal magnetic resonance spectroscopy study of metabolite changes over 2 years in relapsing and primary progressive multiple sclerosis treated with ocrelizumab.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same journal

Racial identity, marginalization, and depression in pediatric-onset multiple sclerosis.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same journal

Disability and race in MS: Does socioeconomic disadvantage play a role?

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
See all related articles

Diagnosing primary progressive multiple sclerosis (PPMS) can be challenging. Cerebrospinal fluid (CSF) analysis, when used correctly, is a valuable tool for confirming PPMS diagnoses and differentiating it from other neurological conditions.

Area of Science:

  • Neurology
  • Neuroimmunology
  • Neurodegeneration

Background:

  • Primary progressive multiple sclerosis (PPMS) diagnosis requires excluding other chronic neurodegenerative CNS diseases.
  • PPMS is characterized by less inflammation than other MS types, increasing diagnostic complexity.
  • Many conditions mimic PPMS, necessitating precise diagnostic criteria.

Purpose of the Study:

  • To explore the diagnostic utility of cerebrospinal fluid (CSF) in primary progressive multiple sclerosis (PPMS).
  • To outline the current state of CSF analysis for PPMS diagnosis.
  • To highlight CSF's role in differentiating PPMS from other central nervous system (CNS) disorders.

Main Methods:

  • Review of current diagnostic schemes for multiple sclerosis (MS).

Related Experiment Videos

  • Analysis of pathological and imaging studies related to PPMS.
  • Exploration of cerebrospinal fluid (CSF) biomarkers and analysis techniques.

    • Main Results:

    • New MS diagnostic criteria mandate typical MS abnormalities in CSF.
    • PPMS can exist even without typical MS CSF findings.
    • CSF analysis provides crucial insights into the disease process.

    Conclusions:

    • Cerebrospinal fluid (CSF) analysis is essential for diagnosing primary progressive multiple sclerosis (PPMS).
    • Proper utilization of CSF analysis aids in clarifying PPMS diagnoses.
    • CSF findings help distinguish PPMS from other chronic neurodegenerative CNS diseases.